Page 2 - Maneb News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Maneb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Maneb Today - Breaking & Trending Today
Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report)‘s stock had its “speculative buy” rating reissued by equities research analysts at Benchmark in a report issued on Tuesday, Benzinga reports. They currently have a $8.00 price objective on the stock. Benchmark’s target price suggests a potential upside of 151.97% from the stock’s previous close. ANEB has been […] ....
HC Wainwright reaffirmed their buy rating on shares of Anebulo Pharmaceuticals (NASDAQ:ANEB – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The brokerage currently has a $6.00 target price on the stock. HC Wainwright also issued estimates for Anebulo Pharmaceuticals’ Q3 2024 earnings at ($0.11) EPS and FY2024 earnings […] ....
ANEB | Complete Anebulo Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ....
Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Rating) and Shattuck Labs (NASDAQ:STTK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Profitability This table compares Anebulo Pharmaceuticals and Shattuck Labs’ […] ....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Rating) was the target of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 6,500 shares, a decrease of 22.6% from the March 31st total of 8,400 shares. Based on an average trading volume of 4,500 shares, the […] ....